Trade KROS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Keros Therapeutics, Inc. (KROS) is trading at US$11.48, up 2.59% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$218.69M. Over the past 52 weeks, KROS has traded between US$9.69 and US$22.55. On Syfe you can trade KROS with $0 commission and add it to your watchlist.
| Previous close | US$11.19 |
|---|---|
| Market cap | US$218.69M |
| 52-week range | US$9.69 – US$22.55 |
| Volume | 120.72K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Keros Therapeutics, Inc.
Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.
Year: 2020
--BofA Securities Adjusts Keros Therapeutics Price Target to $17 From $20
Aug 11, 12:14 PM · MT Newswires
Keros Therapeutics, Inc. (KROS) stock is trading at US$11.48, +2.59% from the previous close of US$11.19.
The market cap for Keros Therapeutics, Inc. (KROS) stock is approximately US$218.69M.
The 52-week high for Keros Therapeutics, Inc. (KROS) stock is US$22.55.
The 52-week low for Keros Therapeutics, Inc. (KROS) stock is US$9.69.
Keros Therapeutics, Inc. (KROS) does not currently pay a dividend.
Stay on top of KROS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
